Leukemia & Lymphoma, Volume 51, Issue 3 (2010)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 51, Issue 3 (2010)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Volume 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
Rituximab in relapsed aggressive lymphoma: play it again, Sam?
Martin Dreyling & Christian Schmidt
Pages: 355-356
Published online: 12 Feb 2010
CitationforRituximab in relapsed aggressive lymphoma: play it again, Sam? | Full Text | References | PDF (130.8 KB)
  • 396 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Intensive therapies for mantle cell lymphoma: time for a disease-specific approach?
Stephen D. Smith & John W. Sweetenham
Pages: 357-359
Published online: 12 Feb 2010
First Page PreviewforIntensive therapies for mantle cell lymphoma: time for a disease-specific approach? | Full Text | References | PDF (137.4 KB)
  • 468 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle
Ayalew Tefferi & Animesh Pardanani
Pages: 360-362
Published online: 08 Feb 2010
First Page PreviewforTargeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle | Full Text | References | PDF (137.4 KB)
  • 453 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Use of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukemia: translating preclinical findings to clinical practice
Daniel J. DeAngelo & Eyal C. Attar
Pages: 363-375
Published online: 28 Dec 2009
AbstractforUse of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukemia: translating preclinical findings to clinical practice | Full Text | References | PDF (310.1 KB)
  • 371 Views
  • 11 CrossRef citations
  • 0Altmetric
Review Article
The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant
Amin M. Alousi, Joseph Uberti & Voravit Ratanatharathorn
Pages: 376-389
Published online: 08 Feb 2010
AbstractforThe role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant | Full Text | References | PDF (675.1 KB)
  • 382 Views
  • 27 CrossRef citations
  • 0Altmetric
Review Article
Mantle cell lymphoma: Report of the 2009 Mantle Cell Lymphoma Consortium Workshop
Michael E. Williams, Martin H. Dreyling, Brad S. Kahl, John P. Leonard, Owen A. O'connor, Oliver W. Press & Wyndham H. Wilson
Pages: 390-398
Published online: 28 Dec 2009
AbstractforMantle cell lymphoma: Report of the 2009 Mantle Cell Lymphoma Consortium Workshop | Full Text | References | PDF (422.2 KB)
  • 122 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study
Anna Johnston, Fadhela Bouafia-Sauvy, Florence Broussais-Guillaumot, Anne-Sophie Michallet, Catherine Traullé, Gilles Salles & Bertrand Coiffier
Pages: 399-405
Published online: 28 Dec 2009
AbstractforRetreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study | Full Text | References | PDF (406.1 KB)
  • 553 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma
Izidore S. Lossos, Peter J. Hosein, Daniel Morgensztern, Francine Coleman, Maricer P. Escalón, Gerald E. Byrne Jr, Joseph D. Rosenblatt & Gail R. Walker
Pages: 406-414
Published online: 28 Dec 2009
AbstractforHigh rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma | Full Text | References | PDF (533.3 KB)
  • 531 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
A systematic review on Richter syndrome: what is the published evidence?
Stefano Molica
Pages: 415-421
Published online: 18 Jan 2010
AbstractforA systematic review on Richter syndrome: what is the published evidence? | Full Text | References | PDF (330.8 KB)
  • 937 Views
  • 31 CrossRef citations
  • 0Altmetric
Article
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi
Donato Mannina, Stefano Luminari, Alessandra Dondi, Giuseppe Polimeno, Luca Baldini, Caterina Stelitano, Francesco Merli, Matteo Dell'olio, Paolo G. Gobbi, Gianfranco Giglio, Elisa Barbolini, Maura Brugiatelli & Massimo Federico
Pages: 422-429
Published online: 28 Dec 2009
AbstractforLong term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi | Full Text | References | PDF (266.4 KB)
  • 84 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Human immunodeficiency virus-associated anaplastic large cell lymphoma
Kimberly Perez, Jorge Castillo, Bruce J. Dezube & Liron Pantanowitz
Pages: 430-438
Published online: 08 Feb 2010
AbstractforHuman immunodeficiency virus-associated anaplastic large cell lymphoma | Full Text | References | PDF (786.6 KB)
  • 287 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of ‘indeterminate’ reports
Alexandra Thomas, Roger D. Gingrich, Brian J. Smith, Laura Jacobus, Kay Ristow, Cristine Allmer, Matthew J. Maurer, Thomas M. Habermann & Brian K. Link
Pages: 439-446
Published online: 08 Feb 2010
Abstractfor18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of ‘indeterminate’ reports | Full Text | References | PDF (376.5 KB)
  • 82 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas
Eckhart Weidmann, Georg Hess, Kai U. Chow, Stefan W. Krause, Marion Subklewe, Judith Kruse, Katja C. Weisel, Martin Soekler, Soo-Zin Kim, Simone Napieralski, Jürgen Rech, Martin Dreyling, Elke Jäger & Paris S. Mitrou
Pages: 447-455
Published online: 08 Feb 2010
AbstractforA phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas | Full Text | References | PDF (270.8 KB)
  • 264 Views
  • 28 CrossRef citations
  • 0Altmetric
Article
Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia
Harindra Jayasekara, Amalia Karahalios, Surender Juneja, Vicky Thursfield, Helen Farrugia, Dallas R. English & Graham G. Giles
Pages: 456-468
Published online: 08 Feb 2010
AbstractforIncidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia | Full Text | References | PDF (1.1 MB)
  • 233 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma
Klaus Lechner & Yen-An Chen
Pages: 469-474
Published online: 08 Feb 2010
AbstractforParaneoplastic autoimmune cytopenias in Hodgkin lymphoma | Full Text | References | PDF (161.6 KB)
  • 452 Views
  • 41 CrossRef citations
  • 0Altmetric
Article
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remission
Hagop M. Kantarjian, Deborah Thomas, Farhad Ravandi, Stefan Faderl, Guillermo Garcia-Manero, Jianquin Shan, Sherry Pierce, Jorge Cortes & Susan O'Brien
Pages: 475-480
Published online: 18 Jan 2010
AbstractforOutcome of adults with acute lymphocytic leukemia in second or subsequent complete remission | Full Text | References | PDF (299.4 KB)
  • 135 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy
Horatiu Olteanu, Bernard C. Schur, Christopher Bredeson, Ehab Atallah & Steven H. Kroft
Pages: 481-487
Published online: 08 Feb 2010
AbstractforExpression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy | Full Text | References | PDF (477 KB)
  • 419 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Clinical characteristics and outcomes of adults with Philadelphia chromosome positive and/or bcr-abl positive acute lymphoblastic leukemia: a single center study from China
Yenan Li, Dehui Zou, Yaozhong Zhao, Yingchang Mi, Jianxiang Wang & Lugui Qiu
Pages: 488-496
Published online: 08 Feb 2010
AbstractforClinical characteristics and outcomes of adults with Philadelphia chromosome positive and/or bcr-abl positive acute lymphoblastic leukemia: a single center study from China | Full Text | References | PDF (362.1 KB)
  • 228 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Chemokine polymorphisms and lymphoma: a pooled analysis
Paige M. Bracci, Christine F. Skibola, Lucia Conde, Eran Halperin, Tracy Lightfoot, Alex Smith, Randi A. Paynter, Danica R. Skibola, Luz Agana, Eve Roman, Eleanor Kane & John K. Wiencke
Pages: 497-506
Published online: 28 Dec 2009
AbstractforChemokine polymorphisms and lymphoma: a pooled analysis | Full Text | References | PDF (194 KB)
  • 128 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Am80 inhibits stromal cell-derived factor-1-induced chemotaxis in T-cell acute lymphoblastic leukemia cells
Taichi Matsumoto, Shiro Jimi, Shuuji Hara, Yasushi Takamatsu, Junji Suzumiya & Kazuo Tamura
Pages: 507-514
Published online: 08 Feb 2010
AbstractforAm80 inhibits stromal cell-derived factor-1-induced chemotaxis in T-cell acute lymphoblastic leukemia cells | Full Text | References | PDF (550.1 KB)
  • 200 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells
Kwong-Lam Fung, Raymond Hin-Suen Liang & Godfrey Chi-Fung Chan
Pages: 515-522
Published online: 19 Nov 2009
AbstractforVincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells | Full Text | References | PDF (751.1 KB)
  • 197 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters
Suzanne M. Cloonan, Aleksandra Drozgowska, Darren Fayne & D. Clive Williams
Pages: 523-539
Published online: 08 Feb 2010
AbstractforThe antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters | Full Text | References | PDF (1.4 MB)
  • 386 Views
  • 31 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Treatment of aggressive systemic mastocytosis with daclizumab
Alfonso Quintás-Cardama, Hesham M. Amin, Hagop Kantarjian & Srdan Verstovsek
Pages: 540-542
Published online: 28 Dec 2009
First Page PreviewforTreatment of aggressive systemic mastocytosis with daclizumab | Full Text | References | PDF (753.7 KB)
  • 96 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue presenting with cryoglobulinemia and subtle marrow infiltrate
K. F. Wong, W. S. Wong & Lisa L. P. Siu
Pages: 543-545
Published online: 28 Dec 2009
First Page PreviewforExtranodal marginal zone lymphoma of mucosa-associated lymphoid tissue presenting with cryoglobulinemia and subtle marrow infiltrate | Full Text | References | PDF (482.8 KB)
  • 84 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Rituximab-induced fatal interstitial pneumonitis: case report
C. Vulsteke, D. Dierickx, E. Verbeken, P. Wolter, J. Thomas & P. Schöffski
Pages: 546-548
Published online: 28 Dec 2009
First Page PreviewforRituximab-induced fatal interstitial pneumonitis: case report | Full Text | References | PDF (733.3 KB)
  • 255 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Low-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients?
Zhijian Xiao, Liang Liu, Zefeng Xu, Tiejun Qin, Yue Zhang & Tianjiao Zhang
Pages: 549-551
Published online: 29 Dec 2009
First Page PreviewforLow-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients? | Full Text | References | PDF (135.7 KB)
  • 92 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma
Carsten Kobe, Markus Dietlein & Michael Fuchs
Pages: 552-553
Published online: 08 Feb 2010
CitationforInterpretation and validation of interim positron emission tomography in Hodgkin lymphoma | Full Text | References | PDF (127 KB)
  • 46 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma
Arturo Montineri, Luciano Nigro, Annalisa Chiarenza, Licia Larocca, Rosario La Rosa, Carmelo Iacobello, Francesco Di Raimondo & Filippo Fatuzzo
Pages: 554-557
Published online: 08 Feb 2010
First Page PreviewforTelbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma | Full Text | References | PDF (306 KB)
  • 56 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Failure of molecular diagnostics in chronic myeloid leukemia: an aberrant form of e13a2 BCR–ABL transcript causing false-negative results by standard polymerase chain reaction
Tomáš Jurček, Filip Razga, Ivana Jeziskova, Dana Dvorakova, Daniela Zackova, Lenka Tomasikova, Alexandra Oltova & Jiri Mayer
Pages: 558-561
Published online: 12 Feb 2010
First Page PreviewforFailure of molecular diagnostics in chronic myeloid leukemia: an aberrant form of e13a2 BCR–ABL transcript causing false-negative results by standard polymerase chain reaction | Full Text | References | PDF (281.4 KB)
  • 67 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Activity of cetuximab as single agent in a patient with relapsed multiple myeloma
Boris Böll, Dennis A. Eichenauer, Bastian Von Tresckow, Denissa Peine, Michael Hallek, Andreas Engert & Kai Hübel
Pages: 562-564
Published online: 25 Jan 2010
First Page PreviewforActivity of cetuximab as single agent in a patient with relapsed multiple myeloma | Full Text | References | PDF (201.1 KB)
  • 82 Views
  • 3 CrossRef citations
  • 0Altmetric

Correspondence

HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role?
Fabio Forghieri, Leonardo Potenza, Patrizia Barozzi, Daniela Vallerini, Giovanni Riva, Eleonora Zanetti, Chiara Quadrelli, Giuseppe Torelli & Mario Luppi
Pages: 565-567
Published online: 08 Feb 2010
First Page PreviewforHHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? | Full Text | References | PDF (136.3 KB)
  • 75 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles